Panagiotides, N.G.; Weidenhammer, A.; Prausmüller, S.; Stadler, M.; Spinka, G.; Heitzinger, G.; Arfsten, H.; Strunk, G.; Bartko, P.E.; Goliasch, G.;
et al. Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF Registry. Biomedicines 2025, 13, 1846.
https://doi.org/10.3390/biomedicines13081846
AMA Style
Panagiotides NG, Weidenhammer A, Prausmüller S, Stadler M, Spinka G, Heitzinger G, Arfsten H, Strunk G, Bartko PE, Goliasch G,
et al. Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF Registry. Biomedicines. 2025; 13(8):1846.
https://doi.org/10.3390/biomedicines13081846
Chicago/Turabian Style
Panagiotides, Noel G., Annika Weidenhammer, Suriya Prausmüller, Marc Stadler, Georg Spinka, Gregor Heitzinger, Henrike Arfsten, Guido Strunk, Philipp E. Bartko, Georg Goliasch,
and et al. 2025. "Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF Registry" Biomedicines 13, no. 8: 1846.
https://doi.org/10.3390/biomedicines13081846
APA Style
Panagiotides, N. G., Weidenhammer, A., Prausmüller, S., Stadler, M., Spinka, G., Heitzinger, G., Arfsten, H., Strunk, G., Bartko, P. E., Goliasch, G., Hengstenberg, C., Hülsmann, M., & Pavo, N.
(2025). Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF Registry. Biomedicines, 13(8), 1846.
https://doi.org/10.3390/biomedicines13081846
